| 标题 |
专利、报告等 Abstract CT299: Dirozalkib versus crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): Results from the multicenter, randomized, open-label phase 3 trial |
| 网址 | |
| DOI |
10.1158/1538-7445.am2026-ct299
doi
|
| 其它 |
期刊:Cancer Research 作者:Ying Liu; Xiangjiao Meng; Yan Yu; Jianhua Chen; Runxiang Yang; et al 出版日期:2026-04-18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)